Total Payments
$23,023
2024 Payments
$1,311
Companies
52
Transactions
590
Medicare Patients
5,740
Medicare Billing
$329,136
Payment Breakdown by Category
Research$10,445 (45.4%)
Food & Beverage$8,973 (39.0%)
Travel$3,575 (15.5%)
Education$30.04 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $10,445 | 3 | 45.4% |
| Food and Beverage | $8,973 | 572 | 39.0% |
| Travel and Lodging | $3,575 | 10 | 15.5% |
| Education | $30.04 | 5 | 0.1% |
Payments by Type
General
$12,578
587 transactions
Research
$10,445
3 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eli Lilly and Company | $10,445 | 3 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $2,548 | 58 | $0 (2024) |
| PFIZER INC. | $1,793 | 36 | $0 (2024) |
| Shionogi Inc | $1,345 | 7 | $0 (2017) |
| Novo Nordisk Inc | $1,012 | 74 | $0 (2024) |
| Lilly USA, LLC | $679.98 | 45 | $0 (2024) |
| ABBVIE INC. | $666.93 | 46 | $0 (2024) |
| GlaxoSmithKline, LLC. | $487.15 | 37 | $0 (2023) |
| Amgen Inc. | $442.07 | 31 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $427.64 | 29 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,311 | 71 | ABBVIE INC. ($183.86) |
| 2023 | $945.57 | 56 | AbbVie Inc. ($219.37) |
| 2022 | $810.92 | 49 | ABBVIE INC. ($194.48) |
| 2021 | $371.51 | 24 | Boehringer Ingelheim Pharmaceuticals, Inc. ($47.09) |
| 2020 | $691.00 | 53 | AstraZeneca Pharmaceuticals LP ($129.55) |
| 2019 | $4,984 | 84 | Eli Lilly and Company ($2,491) |
| 2018 | $9,396 | 110 | Eli Lilly and Company ($7,955) |
| 2017 | $4,513 | 143 | AstraZeneca Pharmaceuticals LP ($1,805) |
All Payment Transactions
590 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: Oncology | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: Respiratory | ||||||
| 12/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.57 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: PAIN | ||||||
| 11/12/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $32.10 | General |
| Category: General - Pain Management_NMD | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: Respiratory | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: VACCINES | ||||||
| 10/28/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Diabetes | ||||||
| 10/21/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: Bone Health | ||||||
| 10/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: Obesity | ||||||
| 10/09/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: PSYCHIATRY | ||||||
| 10/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Gastroenterology | ||||||
| 10/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.23 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: Oncology | ||||||
| 09/09/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: NEUROSCIENCE | ||||||
| 08/28/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: Diabetes | ||||||
| 08/27/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: PAIN | ||||||
| 08/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: Diabetes | ||||||
| 07/31/2024 | WATERMARK MEDICAL, INC. | ARES 620 UNICORDER (Device) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: VENTILATORY EFFORT RECORDER | ||||||
| 07/29/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Diabetes | ||||||
| 07/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Cardiovascular and Metabolism | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A RANDOMIZED, DOUBLE-BLIND, PARALLEL ARM STUDY OF THE EFFICACY AND SAFETY OF INVESTIGATIONAL DULAGLUTIDE DOSES WHEN ADDED TO METFORMIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS | Eli Lilly and Company | $10,445 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,355 | 2,379 | $448,377 | $65,189 |
| 2022 | 12 | 1,442 | 2,333 | $439,342 | $67,999 |
| 2021 | 13 | 1,353 | 2,713 | $413,867 | $73,772 |
| 2020 | 17 | 1,590 | 2,676 | $405,884 | $122,176 |
Total Patients
5,740
Total Services
10,101
Medicare Billing
$329,136
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 322 | 640 | $147,840 | $24,661 | 16.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 256 | 393 | $121,830 | $13,501 | 11.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 305 | 305 | $111,630 | $10,808 | 9.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 145 | 213 | $33,441 | $7,887 | 23.6% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 27 | 36 | $7,200 | $3,209 | 44.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 33 | 34 | $5,168 | $1,408 | 27.2% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 16 | 16 | $2,928 | $1,202 | 41.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 97 | 99 | $6,831 | $902.18 | 13.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 42 | 52 | $4,264 | $539.04 | 12.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 16 | 16 | $1,312 | $482.40 | 36.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 69 | 548 | $2,740 | $423.16 | 15.4% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 16 | 16 | $3,072 | $128.82 | 4.2% |
| 81002 | Urinalysis, manual test | Office | 2023 | 11 | 11 | $121.00 | $37.51 | 31.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 263 | 459 | $142,290 | $18,410 | 12.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 235 | 380 | $87,780 | $16,483 | 18.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 306 | 306 | $111,996 | $12,404 | 11.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 243 | 306 | $48,042 | $5,756 | 12.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 61 | 76 | $11,552 | $4,932 | 42.7% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 34 | 39 | $7,800 | $3,139 | 40.2% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 31 | 31 | $5,673 | $2,166 | 38.2% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 13 | 13 | $6,461 | $1,815 | 28.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 131 | 133 | $9,177 | $1,306 | 14.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 31 | 31 | $2,542 | $911.34 | 35.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 65 | 517 | $2,585 | $399.65 | 15.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 29 | 42 | $3,444 | $276.37 | 8.0% |
About Dr. Jerome Daniel, MD
Dr. Jerome Daniel, MD is a Family Medicine healthcare provider based in North Chesterfield, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1790770329.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jerome Daniel, MD has received a total of $23,023 in payments from pharmaceutical and medical device companies, with $1,311 received in 2024. These payments were reported across 590 transactions from 52 companies. The most common payment nature is "" ($10,445).
As a Medicare-enrolled provider, Daniel has provided services to 5,740 Medicare beneficiaries, totaling 10,101 services with total Medicare billing of $329,136. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location North Chesterfield, VA
- Active Since 09/20/2005
- Last Updated 01/27/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1790770329
Products in Payments
- TRULICITY (Drug) $10,828
- FARXIGA (Drug) $365.92
- Ozempic (Drug) $344.09
- JARDIANCE (Drug) $317.13
- QULIPTA (Drug) $305.27
- TRELEGY ELLIPTA (Drug) $284.47
- XIFAXAN (Drug) $278.53
- VRAYLAR (Drug) $246.33
- JANUVIA (Drug) $236.32
- UBRELVY (Drug) $235.73
- TOUJEO (Drug) $214.05
- NURTEC ODT (Drug) $213.91
- SYMBICORT (Drug) $192.98
- BREZTRI (Drug) $175.87
- Aimovig (Biological) $170.07
- Wegovy (Drug) $163.15
- Tresiba (Drug) $154.28
- SOLIQUA (Drug) $148.58
- MOUNJARO (Drug) $129.72
- Victoza (Drug) $120.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in North Chesterfield
Sara Breeden, Md, MD
Family Medicine — Payments: $7,527
Family Medicine $7,527
Stephen Reinhardt, Md, MD
Family Medicine — Payments: $5,652
Family Medicine $5,652
Caroline Cella, Md, MD
Family Medicine — Payments: $5,070
Family Medicine $5,070
Dr. Caroline Blevins
Family Medicine — Payments: $4,853
Family Medicine $4,853
Dr. Rachael Monroe, M.d, M.D
Family Medicine — Payments: $3,658
Family Medicine $3,658
Rafia Samdani, Md, MD
Family Medicine — Payments: $3,130
Family Medicine $3,130